封面
市場調查報告書
商品編碼
1705795

血小板濃縮系統市場(按技術、應用、最終用戶和地區)

Platelet Concentration Systems Market, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球血小板濃縮器市場規模估計為 5.458 億美元,預計到 2032 年將達到 10.911 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 10.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 5.458億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 10.40% 2032年價值預測 10.911億美元
數字。 2025年血小板濃縮系統各地區市場佔有率(%)
血小板濃縮系統市場-IMG1

血小板濃縮系統是用於濃縮從捐贈血液中收集的血小板的重要醫療設備。從這些系統中獲得的富血小板血漿(PRP)比正常血液含有更高的血小板密度。 PRP 被定義為血小板濃度高於正常血漿的血漿,是透過自體血液的離心或重力過濾產生的。 PRP 廣泛應用於各種再生醫學應用,包括治療肌肉、骨骼和關節損傷的整形外科手術。該系統採用先進技術,透過離心將血小板與其他血液成分精確分離,然後小心地將它們壓縮成濃縮製劑。它提供安全且臨床有效量的自體 PRP 來增強身體的自然癒合過程。隨著全球人口老化和運動傷害的增加,對微創血小板富集技術的需求日益增加。

市場動態:

全球血小板濃縮系統市場受到慢性疾病、運動傷害和創傷性損傷發病率上升的推動,這些疾病可以從 PRP 療法中受益匪淺。重組手術中組織工程方法的採用日益增多以及傷口護理中對血液衍生產品的依賴日益增加,正在推動市場成長。然而,這些設備成本高昂,而且一些地區缺乏基於 PRP 的治療報銷政策,阻礙了它們的廣泛應用。此外,每個系統都需要監管部門的批准,這對市場進入者來說是一個挑戰。尚未開發的商機存在於人口老化的新興經濟體以及利用血小板濃縮物進行新的醫療應用。預計在預測期內,持續的研究和開發將提高濃縮精度、實現流程自動化並擴大應用範圍,從而帶來良好的前景。

本研究的主要特點

  • 本報告對全球血小板濃縮系統市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2024-2030 年)的市場規模和年複合成長率(CAGR%)。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 全球血小板濃縮系統市場的主要企業根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行分析。
  • 本研究介紹的主要企業包括 Anthrax Inc.、Stryker Corporation、Johnson & Johnson's、Zimmer Biomet Holdings Inc.、Terumo Corporation、Arteriocyte Medical Systems, Inc.、Exactech Inc.、Harvest Technologies Corp.、Nuo Therapeutics, Inc.、Haemonetics Corporation、Fresenius & SECo.K、MacSCo.K、St照
  • 本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球血小板濃縮系統市場報告涉及該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員將透過用於分析全球血小板濃縮系統市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球血小板濃縮系統市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球血小板濃縮系統市場(依技術分類),2020 年至 2032 年

  • 血液分離技術
  • 單次旋轉技術
  • 雙旋技術

6. 全球血小板濃縮系統市場(依應用分類),2020 年至 2032 年

  • 整形外科
  • 整形外科和皮膚科
  • 神經病學
  • 心臟病學
  • 其他(眼科等)

7. 全球血小板濃縮系統市場(以最終用戶分類),2020 年至 2032 年

  • 醫院
  • 血庫和輸血中心
  • 門診手術中心
  • 其他(研究設施、獨立處理設施)

8. 2020 年至 2032 年全球血小板濃縮系統市場(按地區)

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭態勢

  • Anthrax Inc.
  • Stryker Corporation
  • Johnson & Johnson's
  • Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Arteriocyte Medical Systems, Inc.
  • Exactech Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc.
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Macopharma
  • BioIVT
  • Stago
  • Pall Corporation

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI4324

Global Platelet Concentration Systems Market is estimated to be valued at USD 545.8 Mn in 2025 and is expected to reach USD 1,091.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 545.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.40% 2032 Value Projection: USD 1,091.1 Mn
Figure. Platelet Concentration Systems Market Share (%), By Region 2025
Platelet Concentration Systems Market - IMG1

Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as plasma with an elevated platelet concentration over that of normal plasma and can be created using centrifugation or gravity filtration of autologous blood. PRP is being extensively used in various regenerative medicine applications such as orthopedic surgeries for treating muscle, bone and joint injuries. The systems are equipped with advanced technologies that precisely separate platelets from other blood components through centrifugation followed by their careful compression into a concentrated formulation. They deliver safe and clinically effective volumes of autologous PRP which boost the body's natural healing abilities. With the aging global population and rise in sports injuries, the demand for less invasive platelet concentration techniques is augmenting.

Market Dynamics:

The global platelet concentration systems market is driven by the rising incidence of chronic diseases, sports injuries, and trauma cases that considerably benefit from PRP therapies. The growing adoption of tissue engineering approaches in reconstructive procedures and an increasing dependence on blood-derived products for wound care are fueling the market growth. However, high costs associated with these devices and lack of reimbursement policies for PRP-based treatments in some regions can impede widespread adoption. Moreover, each system requiring regulatory clearances poses challenges for market players. The untapped opportunities lie in developing economies with large geriatric populations and in utilizing platelet concentrate for new medical applications. Ongoing R&D for improving concentration accuracy, automating the process and expanding indications are expected to create lucrative prospects over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global platelet concentration systems market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2030), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global platelet concentration systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Macopharma, BioIVT, Stago, and Pall Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global platelet concentration systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet concentration systems market

Platelet Concentration Systems Market Detailed Segmentation:

  • By Technology
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • By Application
    • Orthopedics
    • Cosmetic Surgery and Dermatology
    • Neurology
    • Cardiology
    • Others (Ophthalmology and Others)
  • By End User
    • Hospital
    • Blood Banks and Transfusion Centers
    • Ambulatory Surgical Centers
    • Others (Research Laboratories, Stand-alone Processing Facilities)
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Anthrax Inc.
    • Stryker Corporation
    • Johnson & Johnson's
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Arteriocyte Medical Systems, Inc.
    • Exactech Inc.
    • Harvest Technologies Corp.
    • Nuo Therapeutics, Inc.
    • Haemonetics Corporation
    • Fresenius SE & Co. KGaA
    • Macopharma
    • BioIVT
    • Stago
    • Pall Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Platelet Concentration Systems Market, By Technology
    • Global Platelet Concentration Systems Market, By Application
    • Global Platelet Concentration Systems Market, By End User
    • Global Platelet Concentration Systems Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Platelet Concentration Systems Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Platelet Concentration Systems Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Apheresis Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Single Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Double Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Platelet Concentration Systems Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cosmetic Surgery and Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Ophthalmology and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Platelet Concentration Systems Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Blood Banks and Transfusion Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Research Laboratories, Stand-alone Processing Facilities)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Platelet Concentration Systems Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Anthrax Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson's
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Arteriocyte Medical Systems, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Exactech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Harvest Technologies Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nuo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Haemonetics Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fresenius SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Macopharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioIVT
  • Stago
  • Pall Corporation
  • Analyst Views

10. Section

  • Research Methodology
  • About us